Antiplatelet treatment for secondary prevention of acute ischemic stroke and transient ischemic attacks: mechanisms, choices and possible emerging patterns of use

Expert Rev Cardiovasc Ther. 2003 Nov;1(4):611-5. doi: 10.1586/14779072.1.4.611.

Authors

Majaz Moonis¹, Marc Fisher

Affiliation

¹ Department of Neurology, University of Massachusetts Medical School, Worcester 01655, USA. moonism@ummhc.org

PMID: 15030260
DOI: 10.1586/14779072.1.4.611

No abstract available

Publication types

Review

MeSH terms

Aspirin / administration & dosage
Aspirin, Dipyridamole Drug Combination
Clopidogrel
Dipyridamole / administration & dosage
Drug Combinations
Humans
Ischemic Attack, Transient / drug therapy
Ischemic Attack, Transient / prevention & control*
Platelet Aggregation Inhibitors / administration & dosage*
Secondary Prevention
Stroke / drug therapy
Stroke / prevention & control*
Ticlopidine / administration & dosage
Ticlopidine / analogs & derivatives*

Substances

Aspirin, Dipyridamole Drug Combination
Drug Combinations
Platelet Aggregation Inhibitors
Dipyridamole
Clopidogrel
Ticlopidine
Aspirin